H3.3/ATRX- and ATRX-only-mutated GBM tumors often carry p53 mutations, suggesting that loss of p53 tumor suppressive function cooperates with H3.3 and/or ATRX mutations for tumorigenesis. This evidence concerns the gene TP53 and glioblastoma.